Potential therapeutic drugs for ischemic stroke based on bioinformatics analysis

References

• Donnan GA, Fisher M, Macleod M, et al. Stroke. Lancet. 2008;371:1612–1623.
   PubMed Web of Science ®Google Scholar
• Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics – 2014 update: a report from the American Heart Association. Circulation. 2014;129:e28–e292.
   PubMed Web of Science ®Google Scholar
• Evers SM, Struijs JN, Ament AJ, et al. International comparison of stroke cost studies. Stroke. 2004;35:1209–1215.
   PubMed Web of Science ®Google Scholar
• O'Donnell MJ, Xavier D, Liu L, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the interstroke study): a case-control study. Lancet. 2010;376:112–123.
   PubMed Web of Science ®Google Scholar
• Rubattu S, Giliberti R, Volpe M. Etiology and pathophysiology of stroke as a complex trait. Am J Hypertens. 2000;13:1139–1148.
   PubMed Web of Science ®Google Scholar
• Kostulas N, Pelidou SH, KivisäKk P, et al. Increased il-1beta, il-8, and il-17 mRNA expression in blood mononuclear cells observed in a prospective ischemic stroke study. Stroke. 1999;30:2174–2179.
   PubMed Web of Science ®Google Scholar
• Ritter LS, Orozco JA, Coull BM, et al. Leukocyte accumulation and hemodynamic changes in the cerebral microcirculation during early reperfusion after stroke. Stroke. 2000;31:1153–1161.
   PubMed Web of Science ®Google Scholar
• Zhang YD, Gu XH, Dai RY, et al. Screening of differentially expressed genes of middle cerebral artery occlusion with DNA microarray. Eur Rev Med Pharmacol Sci. 2013;17:1205–1210.
   PubMed Web of Science ®Google Scholar
• Ramos-Cejudo J, Gutierrez-Fernandez M, Rodriguez-Frutos B, et al. Spatial and temporal gene expression differences in core and periinfarct areas in experimental stroke: a microarray analysis. PLoS One. 2012;7:e52121.
   PubMed Web of Science ®Google Scholar
• Moore DF, Li H, Jeffries N, et al. Using peripheral blood mononuclear cells to determine a gene expression profile of acute ischemic stroke: a pilot investigation. Circulation. 2005;111:212–221.
   PubMed Web of Science ®Google Scholar
• Tang Y, Xu H, Du X, et al. Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study. J Cereb Blood Flow Metab. 2006;26:1089–1102.
   PubMed Web of Science ®Google Scholar
• Barrett T, Troup DB, Wilhite SE, et al. Ncbi geo: mining tens of millions of expression profiles – database and tools update. Nucleic Acids Res. 2007;35:D760–D765.
   PubMed Web of Science ®Google Scholar
• Barr TL, Conley Y, Ding J, et al. Genomic biomarkers and cellular pathways of ischemic stroke by RNA gene expression profiling. Neurology. 2010;75:1009–1014.
   PubMed Web of Science ®Google Scholar
• Kidwell CS, Warach S. Acute ischemic cerebrovascular syndrome: diagnostic criteria. Stroke. 2003;34:2995–2998.
   PubMed Web of Science ®Google Scholar
• Smyth GK. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004;3:1–25.
   PubMedGoogle Scholar
• Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology. The gene ontology consortium. Nat Genet. 2000;25:25–29.
   PubMed Web of Science ®Google Scholar
• Hulsegge I, Kommadath A, Smits MA. Globaltest and goeast: two different approaches for gene ontology analysis. BMC Proc. 2009;3: S10.
   PubMedGoogle Scholar
• Frohlich H, Speer N, Poustka A, et al. Gosim – an r-package for computation of information theoretic go similarities between terms and gene products. BMC Bioinformat. 2007;8:166.
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Franceschini A, Kuhn M, et al. The string database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res. 2011;39:D561–D568.
   PubMed Web of Science ®Google Scholar
• Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498–2504.
   PubMed Web of Science ®Google Scholar
• Cotto KC, Wagner AH, Feng YY, et al. Dgidb 3.0: a redesign and expansion of the drug-gene interaction database. Nucleic Acids Res. 2018;46:D1068–D1073.
   PubMedGoogle Scholar
• Fu G, Batchelor C, Dumontier M, et al. Pubchemrdf: towards the semantic annotation of pubchem compound and substance databases. J Cheminform. 2015;7:34.
   PubMed Web of Science ®Google Scholar
• Chen Q, Jin M, Yang F, et al. Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling. Mediators Inflamm. 2013;2013:1.
   Web of Science ®Google Scholar
• Siefert SA, Sarkar R. Matrix metalloproteinases in vascular physiology and disease. Vascular. 2012;20:210–216.
   PubMed Web of Science ®Google Scholar
• Katakami N, Takahara M, Kaneto H, et al. Accumulation of gene polymorphisms related to plaque disruption and thrombosis is associated with cerebral infarction in subjects with type 2 diabetes. Diabetes Care. 2010;33:390–395.
   PubMed Web of Science ®Google Scholar
• Newby AC. Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability. ATVB. 2008;28:2108–2114.
   Web of Science ®Google Scholar
• Foerch C, Montaner J, Furie KL, et al. Invited article: searching for oracles? Blood biomarkers in acute stroke. Neurology. 2009;73:393–399.
   PubMed Web of Science ®Google Scholar
• Romanic AM, White RF, Arleth AJ, et al. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke. 1998;29:1020–1030.
   PubMed Web of Science ®Google Scholar
• Loftus IM, Naylor AR, Goodall S, et al. Increased matrix metalloproteinase-9 activity in unstable carotid plaques. A potential role in acute plaque disruption. Stroke. 2000;31:40–47.
   PubMed Web of Science ®Google Scholar
• Ravetch JV, Bolland S. Igg fc receptors. Annu Rev Immunol. 2001;19:275–290.
   PubMed Web of Science ®Google Scholar
• Lee YH, Nath SK. Systemic lupus erythematosus susceptibility loci defined by genome scan meta-analysis. Hum Genet. 2005;118:434–443.
   PubMed Web of Science ®Google Scholar
• Choi SJ, Rho YH, Ji JD, et al. Genome scan meta-analysis of rheumatoid arthritis. Rheumatology. 2006;45:166–170.
   PubMed Web of Science ®Google Scholar
• Brown EE, Edberg JC, Kimberly RP. Fc receptor genes and the systemic lupus erythematosus diathesis. Autoimmunity. 2007;40:567–581.
   PubMed Web of Science ®Google Scholar
• Mayadas TN, Tsokos GC, Tsuboi N. Mechanisms of immune complex-mediated neutrophil recruitment and tissue injury. Circulation. 2009;120:2012–2024.
   PubMed Web of Science ®Google Scholar
• Nimmerjahn F, Ravetch JV. Fcgamma receptors as regulators of immune responses. Nat Rev Immunol. 2008;8:34–47.
   PubMed Web of Science ®Google Scholar
• McKinney C, Merriman TR. Meta-analysis confirms a role for deletion in fcgr3b in autoimmune phenotypes. Hum Mol Genet. 2012;21:2370–2376.
   PubMed Web of Science ®Google Scholar
• Yuan J, Zhao D, Wu L, et al. Fcgr3b copy number loss rather than gain is a risk factor for systemic lupus erythematous and lupus nephritis: a meta-analysis. Int J Rheum Dis. 2015;18:392–397.
   PubMed Web of Science ®Google Scholar
• Fernandez-Cadenas I, Mendioroz M, Giralt D, et al. Grecos project (genotyping recurrence risk of stroke): the use of genetics to predict the vascular recurrence after stroke. Stroke. 2017;48:1147–1153.
   PubMed Web of Science ®Google Scholar
• Arboix A, Lopez-Grau M, Casasnovas C, et al. Clinical study of 39 patients with atypical lacunar syndrome. J Neurol Neurosurg Psychiatry. 2006;77:381–384.
   PubMed Web of Science ®Google Scholar